These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10052488)

  • 21. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients.
    Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Wagner S; Chayama K
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):123-7. PubMed ID: 11981335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
    Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
    Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of Helicobacter pylori infection on serum pepsinogens.
    Kikuchi S; Kurosawa M; Sakiyama T; Tenjin H; Miki K; Wada O; Inaba Y
    Jpn J Cancer Res; 2000 May; 91(5):471-6. PubMed ID: 10835490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.
    Kassem E; Naamna M; Mawassy K; Beer-Davidson G; Muhsen K
    Eur J Pediatr; 2017 Aug; 176(8):1099-1105. PubMed ID: 28681188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.
    Iijima K; Koike T; Abe Y; Ara N; Uno K; Imatani A; Ohara S; Shimosegawa T
    J Gastroenterol; 2009; 44(8):819-25. PubMed ID: 19440811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.
    Fabris P; Pilotto A; Bozzola L; Tositti G; Soffiati G; Manfrin V; de Lalla F
    Aliment Pharmacol Ther; 2002 Apr; 16(4):807-11. PubMed ID: 11929400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
    Miftahussurur M; Waskito LA; Aftab H; Vilaichone RK; Subsomwong P; Nusi IA; Syam AF; Ratanachu-Ek T; Doohan D; Siregar G; Rezkitha YAA; Fauzia KA; Mahachai V; Yamaoka Y
    PLoS One; 2020; 15(4):e0230064. PubMed ID: 32271765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.
    Zhang X; Xue L; Xing L; Wang J; Cui J; Mi J; Xing X; Wang J; Du Z; Misumi J; Tian Q; Wang L
    Int J Cancer; 2012 Apr; 130(7):1614-9. PubMed ID: 21547904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori-negative and -positive Japanese subjects.
    Iijima K; Sekine H; Koike T; Imatani A; Ohara S; Shimosegawa T
    J Gastroenterol; 2005 Oct; 40(10):938-44. PubMed ID: 16261430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum gastrin level and pepsinogen I/II ratio as biomarker of Helicobacter pylori chronic gastritis.
    Arinton IG
    Acta Med Indones; 2010 Jul; 42(3):142-6. PubMed ID: 20724767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan.
    Abe Y; Iijima K; Koike T; Asanuma K; Imatani A; Ohara S; Shimosegawa T
    J Gastroenterol Hepatol; 2009 Jan; 24(1):129-34. PubMed ID: 19196398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.
    Osumi H; Fujisaki J; Suganuma T; Horiuchi Y; Omae M; Yoshio T; Ishiyama A; Tsuchida T; Miki K
    PLoS One; 2017; 12(8):e0183980. PubMed ID: 28854276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helicobacter pylori infection increases serum nitrate and nitrite more prominently than serum pepsinogens.
    Kodama K; Sumii K; Kawano M; Kido T; Nojima K; Sumii M; Haruma K; Yoshihara M; Chayama K
    Helicobacter; 2002 Feb; 7(1):9-13. PubMed ID: 12017117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M; Lapina S; Polaka I; Rudzite D; Vilkoite I; Daugule I; Belkovets A; Pimanov S; Makarenko J; Tolmanis I; Lejnieks A; Boka V; Rumba-Rozenfelde I; Vikmanis U
    Medicina (Kaunas); 2014; 50(1):8-13. PubMed ID: 25060199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.
    Sjomina O; Pavlova J; Daugule I; Janovic P; Kikuste I; Vanags A; Tolmanis I; Rudzite D; Polaka I; Kojalo I; Liepniece-Karele I; Isajevs S; Santare D; Pirags V; Pahomova J; Dzerve V; Tzivian L; Erglis A; Leja M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):11-17. PubMed ID: 29557410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.